Fludarabine Monophosphate as First Line Therapy for Chronic Lymphocytic Leukemia (CLL) - 11 Years Clinical Experience

MLA

H. Calvo, et al. “Fludarabine Monophosphate as First Line Therapy for Chronic Lymphocytic Leukemia (CLL) - 11 Years Clinical Experience.” Blood, vol. 108, Nov. 2006, p. 4970. EBSCOhost, https://doi.org/10.1182/blood.v108.11.4970.4970.

APA

H. Calvo, L. Diaz, S. Brignoni, A. Cabrera, N. Iriondo, R. Draper, M. Rivero, J.E. Novoa, A.L. Rojo, M. Pebet, R. De Bellis, B. Beñaran, & A. Luongo. (2006). Fludarabine Monophosphate as First Line Therapy for Chronic Lymphocytic Leukemia (CLL) - 11 Years Clinical Experience. Blood, 108, 4970. https://doi.org/10.1182/blood.v108.11.4970.4970

Chicago

H. Calvo, L. Diaz, S. Brignoni, A. Cabrera, N. Iriondo, R. Draper, M. Rivero, et al. 2006. “Fludarabine Monophosphate as First Line Therapy for Chronic Lymphocytic Leukemia (CLL) - 11 Years Clinical Experience.” Blood 108 (November): 4970. doi:10.1182/blood.v108.11.4970.4970.